We searched PubMed and found 16 studies identified the potential role of MCPH1/BRIT1 in different cancer types such as, lymphoma, chronic myeloid leukemia, cervical cancer, endometrial cancer, hepatocellular carcinoma, renal carcinoma, brain cancer, oral squamous cell carcinoma, melanoma and prostate cancer. This evidence concerns the gene MCPH1 and prostate carcinoma.